Medivie Therapeutic (Israel) Price Prediction
| MDVI Stock | ILA 32.50 0.50 1.56% |
Oversold Vs Overbought
31
Oversold | Overbought |
Using Medivie Therapeutic hype-based prediction, you can estimate the value of Medivie Therapeutic from the perspective of Medivie Therapeutic response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Medivie Therapeutic to buy its stock at a price that has no basis in reality. In that case, they are not buying Medivie because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Medivie Therapeutic after-hype prediction price | ILA 32.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Medivie |
Medivie Therapeutic After-Hype Price Prediction Density Analysis
As far as predicting the price of Medivie Therapeutic at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Medivie Therapeutic or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Medivie Therapeutic, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Medivie Therapeutic Estimiated After-Hype Price Volatility
In the context of predicting Medivie Therapeutic's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Medivie Therapeutic's historical news coverage. Medivie Therapeutic's after-hype downside and upside margins for the prediction period are 27.82 and 37.18, respectively. We have considered Medivie Therapeutic's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Medivie Therapeutic is not too volatile at this time. Analysis and calculation of next after-hype price of Medivie Therapeutic is based on 3 months time horizon.
Medivie Therapeutic Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Medivie Therapeutic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medivie Therapeutic backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Medivie Therapeutic, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.35 | 4.68 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
32.50 | 32.50 | 0.00 |
|
Medivie Therapeutic Hype Timeline
Medivie Therapeutic is now traded for 32.50on Tel Aviv Stock Exchange of Israel. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Medivie is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at -1.35%. %. The volatility of related hype on Medivie Therapeutic is about 0.0%, with the expected price after the next announcement by competition of 32.50. About 72.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 4.53. Medivie Therapeutic had not issued any dividends in recent years. The entity had 1:10 split on the 25th of October 2015. Assuming the 90 days trading horizon the next forecasted press release will be uncertain. Check out Medivie Therapeutic Basic Forecasting Models to cross-verify your projections.Medivie Therapeutic Related Hype Analysis
Having access to credible news sources related to Medivie Therapeutic's direct competition is more important than ever and may enhance your ability to predict Medivie Therapeutic's future price movements. Getting to know how Medivie Therapeutic's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Medivie Therapeutic may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BCOM | B Communications | 0.00 | 0 per month | 1.56 | 0.12 | 4.90 | (3.10) | 16.14 | |
| FEAT | Feat Fund Investments | 0.00 | 0 per month | 0.59 | (0.02) | 0.00 | (1.53) | 18.09 | |
| ICL | ICL Israel Chemicals | 0.00 | 0 per month | 2.16 | (0.03) | 5.55 | (3.18) | 11.77 | |
| ABRA | Abra Information Technologies | 0.00 | 0 per month | 0.00 | (0.07) | 2.53 | (3.22) | 15.52 | |
| GLPL | Golan Plastic | 0.00 | 0 per month | 1.70 | 0.09 | 4.74 | (3.55) | 11.11 | |
| INRM | Inrom Construction Industries | 0.00 | 0 per month | 1.21 | 0.20 | 3.05 | (2.30) | 9.97 | |
| AMAN | Amanet Management Systems | 0.00 | 0 per month | 1.76 | (0.03) | 2.57 | (2.58) | 12.36 |
Medivie Therapeutic Additional Predictive Modules
Most predictive techniques to examine Medivie price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medivie using various technical indicators. When you analyze Medivie charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Medivie Therapeutic Predictive Indicators
The successful prediction of Medivie Therapeutic stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Medivie Therapeutic, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Medivie Therapeutic based on analysis of Medivie Therapeutic hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Medivie Therapeutic's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Medivie Therapeutic's related companies.
Story Coverage note for Medivie Therapeutic
The number of cover stories for Medivie Therapeutic depends on current market conditions and Medivie Therapeutic's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Medivie Therapeutic is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Medivie Therapeutic's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Medivie Therapeutic Short Properties
Medivie Therapeutic's future price predictability will typically decrease when Medivie Therapeutic's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Medivie Therapeutic often depends not only on the future outlook of the potential Medivie Therapeutic's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medivie Therapeutic's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.9 M |
Complementary Tools for Medivie Stock analysis
When running Medivie Therapeutic's price analysis, check to measure Medivie Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medivie Therapeutic is operating at the current time. Most of Medivie Therapeutic's value examination focuses on studying past and present price action to predict the probability of Medivie Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medivie Therapeutic's price. Additionally, you may evaluate how the addition of Medivie Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |